Abstract
Cardiovascular disease represents a massive healthcare burden worldwide. Gender differences in the pathophysiology, presentation and prognosis of cardiovascular disease have been described in the literature. Metabolic syndrome, characterized by a cluster of metabolic abnormalities is associated with increased risk for type 2 diabetes mellitus and atherosclerotic cardiovascular disease. With the global obesity epidemic, the prevalence of metabolic syndrome is rising rapidly in the developed as well as developing world. However, there is considerable variation in the prevalence based on geography, age, sex and, definition used for diagnosis. Data on gender related differences in metabolic syndrome is relatively scarce. Here, we aim to review the gender differences in epidemiology and pathophysiology of metabolic syndrome as well as its individual components. Knowledge of gender differences in metabolic syndrome can help design gender specific preventative and therapeutic strategies that will have a positive impact on overall population health.
Original language | English (US) |
---|---|
Article number | A001 |
Pages (from-to) | 329-338 |
Number of pages | 10 |
Journal | Cardiovascular Drugs and Therapy |
Volume | 29 |
Issue number | 4 |
DOIs | |
State | Published - Jun 11 2015 |
Externally published | Yes |
Keywords
- Cardiovascular disease
- Dyslipidemia
- Gender differences
- Hypertension
- Insulin resistance
- Metabolic syndrome
- Obesity
- Pathophysiology of metabolic syndrome
- Role of hormones in metabolic syndrome
- Sex differences
ASJC Scopus subject areas
- Pharmacology
- Cardiology and Cardiovascular Medicine
- Pharmacology (medical)